Who owns CNS PHARMACEUTICALS INC?

Tip: Access positions for across all investors

Analyze quarterly positions in Cns Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Cns Pharmaceuticals stock

Who bought or sold CNS PHARMACEUTICALS INC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Geode Capital Management 203k $27k 100% Sep 2024
 View chart
UBS Group 182k $24k 6818% Sep 2024
 View chart
Virtu Financial 123k $16k 100% Sep 2024
 View chart
Goldman Sachs Group 28k $3.7k 100% Sep 2024
 View chart
Jane Street 23k $3.0k 100% Sep 2024
 View chart
Tower Research Capital 16k $2.1k 14072% Sep 2024
 View chart
Bank of America Corporation 234.00 $29.998800 23300% Sep 2024
 View chart
Wells Fargo & Company 4.00 $1.000000 0% Sep 2024
 View chart
Global Retirement Partners 2.00 $0 0% Sep 2024
 View chart
Northwestern Mutual Wealth Management Company 1.00 $0 100% Sep 2024
 View chart
Plante Moran Financial Advisors 1.00 $0 0% Sep 2024
 View chart
Parallel Advisors 1.00 $0 0% Sep 2024
 View chart

Who sold out of Cns Pharmaceuticals?

Fund or Company Name Date Sold Shares Held Valued At
Frigate Ventures Jun 2024 141k $223k
Aspire Private Capital Sep 2024 400.00 $52.000000
FMR Jun 2024 1.00 $2.000000